Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
FTC Launches Task Force to Tackle Healthcare Consolidation
Public Policy FTC Launches Task Force to Tackle Healthcare Consolidation

The American healthcare economy has reached a staggering threshold where its total valuation accounts for nearly 18% of the national Gross Domestic Product, yet this massive financial output often fails to deliver proportional value to the average citizen. This economic weight makes the sector a

Is Healthcare AI Regulation Still a Wild West?
Public Policy Is Healthcare AI Regulation Still a Wild West?

The transition from human-only clinical oversight to algorithm-assisted decision-making has occurred with such velocity that traditional legal safeguards now appear to be running several miles behind the technology they are meant to govern. While patients and providers increasingly rely on

Spain Guarantees Free Healthcare for Undocumented Migrants
Public Policy Spain Guarantees Free Healthcare for Undocumented Migrants

The foundational belief that medical assistance should be a fundamental human right rather than a privilege reserved for those with legal residency papers has long defined the Spanish social contract. While many nations struggle with the complexities of managing growing migrant populations, Spain

Global Medical Radiation Shielding Market Analysis and Trends
Public Policy Global Medical Radiation Shielding Market Analysis and Trends

The quiet humming of a linear accelerator or the rapid click of a high-speed computed tomography scanner represents the pinnacle of modern diagnostic and therapeutic precision, yet these lifesaving technologies would be entirely unusable without the sophisticated engineering of the medical

Can States Protect Your Right to No-Cost Birth Control?
Public Policy Can States Protect Your Right to No-Cost Birth Control?

The legal architecture of American reproductive healthcare is currently facing a transformative period as the promise of universal, no-cost contraception encounters significant regulatory and judicial pushback. Since the implementation of the Affordable Care Act, the mandate for preventative

How Is Telemedicine Shaping the European Medical Cannabis Market?
Public Policy How Is Telemedicine Shaping the European Medical Cannabis Market?

The rapid expansion of specialized digital health platforms has fundamentally altered how patients interact with the medical cannabis market across the European continent through the use of integrated technological solutions. Digital prescription platforms and cross-border physician networks now

Texas AG Expands Gender Transition Ban to Mental Health Care
Public Policy Texas AG Expands Gender Transition Ban to Mental Health Care

The professional boundary between a therapist’s private consultation room and the state's executive chambers has dissolved as Texas transforms the landscape of pediatric behavioral health into a strictly regulated legal territory. While the initial wave of restrictions focused primarily on the

How Will Malta’s New Living Will Law Protect Patient Dignity?
Public Policy How Will Malta’s New Living Will Law Protect Patient Dignity?

The struggle between modern medical capabilities and the fundamental human right to a dignified natural death has reached a pivotal turning point in the Mediterranean. Malta is currently moving away from traditional medical paternalism toward a modern model centered on patient sovereignty and

How Will the New CRUSH Initiative Combat Healthcare Fraud?
Public Policy How Will the New CRUSH Initiative Combat Healthcare Fraud?

The federal government is fundamentally reshaping its approach to protecting taxpayer dollars by dismantling the traditional reactive mechanisms of the past while prioritizing immediate prevention. For decades, Medicare and Medicaid operated under a pay-and-chase philosophy that allowed billions to

Why Did the FDA Pause the Lorigerlimab LINNET Trial?
Public Policy Why Did the FDA Pause the Lorigerlimab LINNET Trial?

The landscape of gynecologic oncology treatment is undergoing a radical transformation as researchers attempt to bypass the limitations of traditional platinum-based chemotherapy through advanced molecular engineering. Modern oncology is currently defined by a move toward targeted therapies for

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later